The DOI matches its Crossref record; 66 of the 66 references it cites were found in a registry or an index.
Decreased Serum Brain-Derived Neurotrophic Factor (BDNF) Levels in Patients with Alzheimer’s Disease (AD): A Systematic Review and Meta-Analysis
Open accessAbstract
Findings from previous studies reporting the levels of serum brain-derived neurotrophic factor (BDNF) in patients with Alzheimer’s disease (AD) and individuals with mild cognitive impairment (MCI) have been conflicting. Hence, we performed a meta-analysis to examine the aggregate levels of serum BDNF in patients with AD and individuals with MCI, in comparison with healthy controls. Fifteen studies were included for the comparison between AD and healthy control (HC) (n = 2067). Serum BDNF levels were significantly lower in patients with AD (SMD: −0.282; 95% confidence interval [CI]: −0.535 to −0.028; significant heterogeneity: I2 = 83.962). Meta-regression identified age (p < 0.001) and MMSE scores (p < 0.001) to be the significant moderators that could explain the heterogeneity in findings in these studies. Additionally, there were no significant differences in serum BDNF levels between patients with AD and MCI (eight studies, n = 906) and between MCI and HC (nine studies, n = 5090). In all, patients with AD, but not MCI, have significantly lower serum BDNF levels compared to healthy controls. This meta-analysis confirmed the direction of change in serum BDNF levels in dementia. This finding suggests that a significant change in peripheral BDNF levels can only be detected at the late stage of the dementia spectrum. Molecular mechanisms, implications on interventional trials, and future directions for studies examining BDNF in dementia were discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Keleshian, V. L., Modi, H. R., Rapoport, S. I., & Rao, J. S. (2013) · Journal of Neurochemistry · doi:10.1111/jnc.12153 · Cited by 56
RetractedEstimating the mean and variance from the median, range, and the size of a sample
Hozo, S. P., Djulbegovic, B., & Hozo, I. (2005) · BMC Medical Research Methodology · doi:10.1186/1471-2288-5-13 · Cited by 9,062
Exercise training increases size of hippocampus and improves memory
Erickson, K. I., Voss, M. W., Prakash, R. S., Basak, C., Szabo, A., Chaddock, L., Kim, J. S., Heo, S., Alves, H., White, S. M., et al. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1015950108 · Cited by 4,855
Neuropathological alterations in Alzheimer disease
Serrano-Pozo, A., Frosch, M. P., Masliah, E., & Hyman, B. T. (2011) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a006189 · Cited by 3,345 · cited 1×
“The pathological changes include the aggregation of amyloid β-42, increased phosphorylated tau leading to the formation of neurofibrillary tangles [5], heightened low-grade inflammation or inflammaging, reduction in cholinergic function [6], and changes in neurotrophic factors such as brain-derived neurotropic factor…”
BackgroundShimizu, E., Hashimoto, K., Okamura, N., Koike, K., Komatsu, N., Kumakiri, C., Nakazato, M., Watanabe, H., Shinoda, N., Okada, S.-I., et al. (2003) · Biological Psychiatry · doi:10.1016/s0006-3223(03)00181-1 · Cited by 1,151 · cited 1×
“have their serum BDNF levels recovered to basal levels as well [30].”
BackgroundSex differences in Alzheimer disease — the gateway to precision medicine
for the Women’s Brain Project and the Alzheimer Precision Medicine Initiative, Ferretti, M. T., Iulita, M. F., Cavedo, E., Chiesa, P. A., Schumacher Dimech, A., Santuccione Chadha, A., Baracchi, F., Girouard, H., Misoch, S., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0032-9 · Cited by 1,009
FERRIS, L. T., WILLIAMS, J. S., & SHEN, C.-L. (2007) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e31802f04c7 · Cited by 849 · cited 1×
“found that serum BDNF levels were significantly increased after exercising, and the higher the intensity of the exercises, the higher the increases in BDNF levels [55].”
BackgroundIndependent cellular processes for hippocampal memory consolidation and reconsolidation
Lee, J. L. C., Everitt, B. J., & Thomas, K. L. (2004) · Science · doi:10.1126/science.1095760 · Cited by 825
Brain-derived Neurotrophic Factor Is Stored in Human Platelets and Released by Agonist Stimulation
Fujimura, H., Chen, R., Nakamura, T., Nakahashi, T., Kambayashi, J.-I., Sun, B., Altar, C., & Tandon, N. (2002) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1613072 · Cited by 777
A BDNF autocrine loop in adult sensory neurons prevents cell death
Acheson, A., Conover, J. C., Fandl, J. P., DeChiara, T. M., Russell, M., Thadani, A., Squinto, S. P., Yancopoulos, G. D., & Lindsay, R. M. (1995) · Nature · doi:10.1038/374450a0 · Cited by 765
BDNF-based synaptic repair as a disease-modifying strategy for neurodegenerative diseases
Lu, B., Nagappan, G., Guan, X., Nathan, P. J., & Wren, P. (2013) · Nature Reviews Neuroscience · doi:10.1038/nrn3505 · Cited by 743
Karege, F., Bondolfi, G., Gervasoni, N., Schwald, M., Aubry, J.-M., & Bertschy, G. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.01.008 · Cited by 593
Brain-derived neurotrophic factor is reduced in Alzheimer's disease
Connor, B., Young, D., Yan, Q., Faull, R. L. M., Synek, B., & Dragunow, M. (1997) · Molecular Brain Research · doi:10.1016/s0169-328x(97)00125-3 · Cited by 581
Lee, J., Duan, W., Long, J. M., Ingram, D. K., & Mattson, M. P. (2000) · Journal of Molecular Neuroscience · doi:10.1385/jmn:15:2:99 · Cited by 408
A panel of cerebrospinal fluid potential biomarkers for the diagnosis of Alzheimer's disease
Carrette, O., Demalte, I., Scherl, A., Yalkinoglu, O., Corthals, G., Burkhard, P., Hochstrasser, D. F., & Sanchez, J. (2003) · PROTEOMICS · doi:10.1002/pmic.200300470 · Cited by 374
Mowla, S. J., Pareek, S., Farhadi, H. F., Petrecca, K., Fawcett, J. P., Seidah, N. G., Morris, S. J., Sossin, W. S., & Murphy, R. A. (1999) · The Journal of Neuroscience · doi:10.1523/jneurosci.19-06-02069.1999 · Cited by 350
miR-206 regulates brain-derived neurotrophic factor in Alzheimer disease model
Lee, S., Chu, K., Jung, K., Kim, J. H., Huh, J., Yoon, H., Park, D., Lim, J., Kim, J., Jeon, D., et al. (2012) · Annals of Neurology · doi:10.1002/ana.23588 · Cited by 326
Stage-dependent BDNF serum concentrations in Alzheimer’s disease
Laske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Wittorf, A., Richartz, E., Bartels, M., Buchkremer, G., & Schott, K. (2006) · Journal of Neural Transmission · doi:10.1007/s00702-005-0397-y · Cited by 324
Xu, Y., Ku, B., Tie, L., Yao, H., Jiang, W., Ma, X., & Li, X. (2006) · Brain Research · doi:10.1016/j.brainres.2006.09.009 · Cited by 298
Wu, A., Ying, Z., & Gomez-Pinilla, F. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.05.061 · Cited by 298
Serum Brain-Derived Neurotrophic Factor and the Risk for Dementia: The Framingham Heart Study
Weinstein, G., Beiser, A. S., Choi, S. H., Preis, S. R., Chen, T. C., Vorgas, D., Au, R., Pikula, A., Wolf, P. A., DeStefano, A. L., et al. (2014) · JAMA Neurology · doi:10.1001/jamaneurol.2013.4781 · Cited by 289 · cited 1×
“By having BDNF levels higher by one standard deviation, the risk for AD or dementia was lowered by 33% [9].”
BackgroundLaske, C., Stransky, E., Leyhe, T., Eschweiler, G. W., Maetzler, W., Wittorf, A., Soekadar, S., Richartz, E., Koehler, N., Bartels, M., et al. (2007) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2006.01.014 · Cited by 272 · cited 4×
“…or non-steroidal anti-inflammatory drugs, had significant laboratory abnormalities, did not have erythrocyte sedimentation rates within reference values; - Laske et al. (2007) [21] Age-matched case-control study - - ELISA kit (R&D Systems GmbH Wiesbaden-Nordenstadt, Germany) Both <10% - - Excluded…”
MethodInfluentialCorticosterone effects on BDNF expression in the hippocampus. Implications for memory formation
Schaaf, M. J. M., De Kloet, E. R., & Vreugdenhil, E. (2000) · Stress · doi:10.3109/10253890009001124 · Cited by 270 · cited 1×
“A study found that corticosterone decreased BDNF expression at both the mRNA and protein levels [40].”
BackgroundLu, B. (2003) · Neuron · doi:10.1016/s0896-6273(03)00538-5 · Cited by 267
Polacchini, A., Metelli, G., Francavilla, R., Baj, G., Florean, M., Mascaretti, L. G., & Tongiorgi, E. (2015) · Scientific Reports · doi:10.1038/srep17989 · Cited by 263
Cattaneo, A., Cattane, N., Begni, V, Pariante, C. M., & Riva, M. A. (2016) · Translational Psychiatry · doi:10.1038/tp.2016.214 · Cited by 244
Serum Brain-Derived Neurotrophic Factor Levels in Different Neurological Diseases
Ventriglia, M., Zanardini, R., Bonomini, C., Zanetti, O., Volpe, D., Pasqualetti, P., Gennarelli, M., & Bocchio-Chiavetto, L. (2013) · BioMed Research International · doi:10.1155/2013/901082 · Cited by 189 · cited 11×
“(2013) [27] Case-control study Human BDNF Quantikine kit (R&D system, Minneapolis, MN, USA) NA, approximately 8% Most subjects took more than one medication concurrently.”
BackgroundInfluentialGezen-Ak, D., Dursun, E., Hanağası, H., Bilgiç, B., Lohman, E., Araz, Ö. S., Atasoy, İ. L., Alaylıoğlu, M., Önal, B., Gürvit, H., et al. (2013) · Journal of Alzheimer's Disease · doi:10.3233/jad-130497 · Cited by 188 · cited 6×
“…elders recruited from an ongoing cohort study Mayo Clinic criteria 0.51 (0.27) 62; M = 17, F= 45 72.2 (6.2) 88; M = 25, F = 63 Gezen-ak et al. (2013) [29] Istanbul, Turkey Behavioral Neurology and Movement Disorder Clinic DSM-VI and MMSE 0.93 (0.31) 76; NA; EOAD = 22, LOAD…”
BackgroundInfluentialShimada, H., Makizako, H., Doi, T., Yoshida, D., Tsutsumimoto, K., Anan, Y., Uemura, K., Lee, S., Park, H., & Suzuki, T. (2014) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2014.00069 · Cited by 188
Angelucci, F., Spalletta, G., Iulio, F., Ciaramella, A., Salani, F., Varsi, A., Gianni, W., Sancesario, G., Caltagirone, C., & Bossu, P. (2010) · Current Alzheimer Research · doi:10.2174/156720510790274473 · Cited by 186
Duan, W., Lee, J., Guo, Z., & Mattson, M. P. (2001) · Journal of Molecular Neuroscience · doi:10.1385/jmn:16:1:1 · Cited by 183
Yasutake, C., Kuroda, K., Yanagawa, T., Okamura, T., & Yoneda, H. (2006) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-006-0652-8 · Cited by 177
Laske, C., Banschbach, S., Stransky, E., Bosch, S., Straten, G., Machann, J., Fritsche, A., Hipp, A., Niess, A., & Eschweiler, G. W. (2010) · The International Journal of Neuropsychopharmacology · doi:10.1017/s1461145709991234 · Cited by 171
Increased CSF cortisol in AD is a function of APOE genotype
Peskind, E. R., Wilkinson, C. W., Petrie, E. C., Schellenberg, G. D., & Raskind, M. A. (2001) · Neurology · doi:10.1212/wnl.56.8.1094 · Cited by 171
Measuring and Validating the Levels of Brain-Derived Neurotrophic Factor in Human Serum
Naegelin, Y., Dingsdale, H., Säuberli, K., Schädelin, S., Kappos, L., & Barde, Y. (2018) · eNeuro · doi:10.1523/eneuro.0419-17.2018 · Cited by 171
Blasko, I., Lederer, W., Oberbauer, H., Walch, T., Kemmler, G., Hinterhuber, H., Marksteiner, J., & Humpel, C. (2006) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000089137 · Cited by 170
Zielinski, M. R., Kim, Y., Karpova, S. A., McCarley, R. W., Strecker, R. E., & Gerashchenko, D. (2014) · Neuroscience Letters · doi:10.1016/j.neulet.2014.07.043 · Cited by 170
A New Glucocorticoid Hypothesis of Brain Aging: Implications for Alzheimers Disease
Landfield, P. W., Blalock, E. M., Chen, K.-C., & Porter, N. M. (2007) · Current Alzheimer Research · doi:10.2174/156720507780362083 · Cited by 165
DHA May Prevent Age-Related Dementia
Cole, G. M., & Frautschy, S. A. (2010) · Journal of Nutrition · doi:10.3945/jn.109.113910 · Cited by 163
GSK3β, CREB, and BDNF in peripheral blood of patients with Alzheimer's disease and depression
Pláteník, J., Fišar, Z., Buchal, R., Jirák, R., Kitzlerová, E., Zvěřová, M., & Raboch, J. (2014) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.12.001 · Cited by 161
Marvanová, M., Lakso, M., Pirhonen, J., Nawa, H., Wong, G., & Ċastrén, E. (2001) · Molecular and Cellular Neuroscience · doi:10.1006/mcne.2001.1027 · Cited by 156
Wang, R., Li, Y.-B., Li, Y.-H., Xu, Y., Wu, H., & Li, X.-J. (2008) · Brain Research · doi:10.1016/j.brainres.2008.01.104 · Cited by 151
Leyhe, T., Stransky, E., Eschweiler, G. W., Buchkremer, G., & Laske, C. (2007) · European Archives of Psychiatry and Clinical Neuroscience · doi:10.1007/s00406-007-0764-9 · Cited by 145
Coelho, F. M., Pereira, D. S., Lustosa, L. P., da Silva, J. P., Dias, J. M. D., Dias, R. C., de Queiroz, B. Z., Teixeira, A. L., Teixeira, M. M., & Pereira, L. S. M. (2011) · Archives of Gerontology and Geriatrics · doi:10.1016/j.archger.2011.05.014 · Cited by 139
Does Meditation Enhance Cognition and Brain Plasticity?
Xiong, G. L., & Doraiswamy, P. M. (2009) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1393.002 · Cited by 128
Evans, S. F., Irmady, K., Ostrow, K., Kim, T., Nykjaer, A., Saftig, P., Blobel, C., & Hempstead, B. L. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.219675 · Cited by 124
Decreased Serum Brain-Derived Neurotrophic Factor Levels in Elderly Korean with Dementia
Lee, J. G., Shin, B. S., You, Y. S., Kim, J. E., Yoon, S. W., Jeon, D. W., Baek, J. H., Park, S. W., & Kim, Y. H. (2009) · Psychiatry Investigation · doi:10.4306/pi.2009.6.4.299 · Cited by 121
Cullum, S. J., Huppert, F. A., McGee, M., Dening, T., Ahmed, A., Paykel, E. S., & Brayne, C. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200009)15:9<853::aid-gps211>3.0.co;2-t · Cited by 119
Brain-Derived Neurotrophic Factor Levels in Alzheimer's Disease
O’Bryant, S. E., Hobson, V. L., Hall, J. R., Waring, S. C., Chan, W., Massman, P. J., Lacritz, L. H., Cullum, C. M., & Diaz-Arrastia, R. R. (2009) · Journal of Alzheimer s Disease · doi:10.3233/jad-2009-1051 · Cited by 104
The Interplay of Stress and Sleep Impacts BDNF Level
Giese, M., Unternaehrer, E., Brand, S., Calabrese, P., Holsboer-trachsler, E., & Eckert, A. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076050 · Cited by 102
Positive therapeutic and neurotropic effects of yoga in depression: A comparative study
Thirthalli, J., Naveen, G., Rao, M., Varambally, S. S., Christopher, R., & Gangadhar, B. N. (2013) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.116313 · Cited by 102
Cullum, S. J., Huppert, F. A., McGee, M. A., Dening, T., Ahmed, A., Paykel, E. S., & Brayne, C. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200009)15:9<853::aid-gps211>3.3.co;2-k · Cited by 97
Decreased Neurotrophic Support is Associated with Cognitive Decline in Non-Demented Subjects
Forlenza, O. V., de Miranda, A. S., Guimar, I., Talib, L. L., Diniz, B. S., Gattaz, W. F., & Teixeira, A. L. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150172 · Cited by 92
Plasma BDNF levels vary in relation to body weight in females
Pillai, A., Bruno, D., Sarreal, A. S., Hernando, R. T., Saint-Louis, L. A., Nierenberg, J., Ginsberg, S. D., Pomara, N., Mehta, P. D., Zetterberg, H., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0039358 · Cited by 82 · cited 1×
“Another study on human participants illustrated the importance of controlling body weight on circulating BDNF levels [52].”
BackgroundO’Bryant, S. E., Hobson, V. L., Hall, J. R., Barber, R. C., Zhang, S., Johnson, L. A., & Diaz-Arrastia, R. R. (2010) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000321980 · Cited by 73
for the German Competence Network HIV/AIDS, Meisner, F., Scheller, C., Kneitz, S., Sopper, S., Neuen-Jacob, E., Riederer, P., Meulen, V. T., & Koutsilieri, E. (2008) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301615 · Cited by 73
Gundimeda, U., McNeill, T. H., Fan, T., Deng, R., Rayudu, D. V., Chen, Z., Cadenas, E., & Gopalakrishna, R. (2014) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2014.01.166 · Cited by 70
Neurotransmitter measures in the cerebrospinal fluid of patients with Alzheimer's disease: a review.
Štrac, D. Š., Mück‐Šeler, D., & Pivac, N. (2015) · PubMed · Cited by 63
Apathy and APOE4 are associated with Reduced BDNF Levels in Alzheimer's Disease
Álvarez, A., Aleixandre, M., Linares, C., Masliah, E., & Moessler, H. (2014) · Journal of Alzheimer s Disease · doi:10.3233/jad-140849 · Cited by 62
Olson, L., & Humpel, C. (2009) · Experimental Gerontology · doi:10.1016/j.exger.2009.10.011 · Cited by 59
Stransky, E., Leyhe, T., Eschweiler, G. W., Schott, K. J., Langer, H. F., Gawaz, M., & Laske, C. (2006) · Thrombosis and Haemostasis · doi:10.1160/th06-03-0173 · Cited by 59
Walton, K. G., Fields, J. Z., Levitsky, D. K., HARRIS, D. A., Pugh, N. D., & Schneider, R. H. (2004) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1314.023 · Cited by 57
From microRNA target validation to therapy: lessons learned from studies on BDNF
Varendi, K., Mätlik, K., & Andressoo, J. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1836-z · Cited by 34
Lee, S. J., Baek, J.-H., & Kim, Y.-H. (2015) · Clinical Psychopharmacology and Neuroscience · doi:10.9758/cpn.2015.13.3.283 · Cited by 31
Woolley, J. D., Strobl, E. V., Shelly, W. B., Karydas, A. M., Ketelle, R., Wolkowitz, O. M., Miller, B. L., & Rankin, K. P. (2012) · Current Alzheimer Research · doi:10.2174/156720512802455395 · Cited by 25
P3–340: Decrease of BDNF serum concentration from MCI to early Alzheimer's disease
Laske, C., Stransky, E., Leyhe, T., Koehler, N. K. U., & Schott, K. J. (2006) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2006.05.1610 · Cited by 4
Cited by
Brain-Derived Neurotrophic Factor in Alzheimer’s Disease and Its Pharmaceutical Potential
Gao, L., Zhang, Y., Sterling, K., & Song, W. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00279-0 · Cited by 606
Protective genes and pathways in Alzheimer’s disease: moving towards precision interventions
Seto, M., Weiner, R. L., Dumitrescu, L., & Hohman, T. J. (2021) · Molecular Neurodegeneration · doi:10.1186/s13024-021-00452-5 · Cited by 135
Sarcopenic obesity: Myokines as potential diagnostic biomarkers and therapeutic targets?
Guo, A., Li, K., & Xiao, Q. (2020) · Experimental Gerontology · doi:10.1016/j.exger.2020.111022 · Cited by 83
Can exercise training teach us how to treat Alzheimer's disease?
Huuha, A. M., Norevik, C. S., Moreira, J. B. N., Kobro-Flatmoen, A., Scrimgeour, N., Kivipelto, M., Van Praag, H., Ziaei, M., Sando, S. B., Wisløff, U., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101559 · Cited by 79
Udeh-Momoh, C., & Watermeyer, T. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101459 · Cited by 67
Metadata
- Authors
- Ng, T. K. S., Ho, C. S. H., Tam, W. W. S., Kua, E. H., & Ho, R. C.-M.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-01-10
- Volume
- 20
- Issue
- 2
- Pages
- 257
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2908750541
- Cited by
- 413
- References
- 66
- FWCI
- 9.17
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.